vatalanib has been researched along with Meningioma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chamberlain, M; Chandler, JP; Grimm, SA; Helenowski, I; Johnston, SK; McCarthy, K; Mrugala, MM; Muro, K; Rademaker, A; Raizer, JJ; Rice, L | 1 |
1 trial(s) available for vatalanib and Meningioma
Article | Year |
---|---|
A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain; Brain Neoplasms; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Meningioma; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Phthalazines; Pyridines; Salvage Therapy; Time Factors | 2014 |